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Abstract: Background: Recent studies suggest a potential relationship between Restless Legs Syndrome (RLS) and hy-
pertension and heart disease. Acute clinical stroke has been linked to the immediate onset of RLS, and epidemiological 
studies suggest the possibility that RLS may also lead to stroke. 
Methods: MRI scans from 26 RLS cases and 241 controls from the population based MEMO-Study (Memory and Mor-
bidity in Augsburg Elderly) were assessed for the presence of clinical stroke, silent infarction, subcortical lesions and cor-
tical atrophy. T1, T2, proton density images were obtained and infarcts and their characteristics were determined by visual 
inspection. RLS status was assessed according to the minimal criteria of the International RLS Study Group. Scans from 
the 26 RLS patients and a subset of 26 age and sex matched controls were reexamined by a separate rater using the same 
methodology. Descriptive statistics, logistic and linear regression models were used to determine the risk of the three 
types of CNS changes associated with RLS case status. 
Results: Among the 267 participants there was no difference in the prevalence of cardiovascular diseases or risk factors 
between RLS patients and the 241 controls. The prevalences of cerebrovascular events of all types, were greater in RLS 
patients, as were the amounts of cortical atrophy and the volume of subcortical lesions. However, these differences were 
not statistically significant. When age, sex and co-morbidities were taken into account in a logistic regression model, there 
was a statistically non-significant greater risk for stroke (Odds Ratio 2.46 with 95% CI 0.97-6.28, p = .06) associated with 
RLS case status.  
Conclusions: Future similar studies need to be performed on younger patients without other potential vascular risk factors, 
using Flair images and computerized programs for detection of cerebral ischemia. Improved methods for detection may 
allow for a reasonable sample size.  
Keywords: Magnetic resonance imaging, restless legs syndrome, cerebrovascular disease, stroke, cardiovascular disease, hy-
pertension, periodic limb movements in sleep, leukoaraiosis. 
INTRODUCTION 
  Recent evidence has been accumulating that heart dis-
ease, hypertension and stroke are linked to Restless Legs 
Syndrome/Periodic Limb Movements in Sleep (RLS/PLMS 
[1]. Although the links between RLS and heart disease have 
been quite consistent, an association of RLS with hyperten-
sion is reported in some epidemiological studies [2-4] but 
not in others [5-8]. On the other hand, direct measurement of 
the numbers of PLMS and the level of daytime hypertension 
simultaneously suggest that there is a direct correlation [9, 
10]. Theoretical mechanisms as to how RLS/PLMS might be 
linked to heart disease and stroke in the absence of hyperten-
sion are discussed elsewhere [1]. In three initial independent 
case reports and one larger later case series of 17 of 137 
stroke patients, RLS or its accompanying PLMS, began 
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immediately after acute clinically evident stroke primarily in 
the area of the basal ganglia, corona radiata or other subcor-
tical areas [11-14]. Preliminary results from a small Mag-
netic Resonance Imaging (MRI) study suggest that RLS is 
also associated with silent infarcts [15]. Thus, although 
stroke may lead to RLS/PLMS, the possibility remains that 
RLS/PLMS may also lead to stroke. This possibility was 
explored in an epidemiologic study by Elwood et al. where 
1986 men aged 55-69 years completed a questionnaire re-
garding RLS and other sleep disorders. During the following 
10 years 107 men experienced an ischemic stroke and 213 
had an ischemic heart event. Compared with men who re-
ported no symptoms of sleep disturbance of any kind, the 
relative odds of an ischemic stroke was 1.67 (95% CI: 1.07-
2.60 - P = .024) in patients who responded positively to a 
question on RLS [16]. 
  The aim of our study was to examine the relationship 
between RLS and silent as well as clinically evident stroke 
and subcortical lesions on MRI in a population based study 
of the elderly. 74     The Open Neurology Journal, 2010, Volume 4  Walters et al. 
METHODS 
  The MEMO (Memory and Morbidity in Augsburg Eld-
erly) Study [8] is a follow-up project of the 1989-90 World 
Health Organization “Monitoring Trends and Determinants 
in Cardiovascular Disease” (MONICA) Survey in Augsburg, 
Southern Germany. MEMO examines cognitive function and 
risk factors for neurodegenerative diseases in the elderly. It 
was part of the “Cardiovascular Determinants of Dementia 
(CASCADE) Study” a European multicenter study with the 
objective of evaluating the effects of cardiovascular risk fac-
tors on cerebral morphology among community-dwelling 
elderly men and women. The MEMO Study was restricted to 
participants of the second MONICA survey, who were aged 
65 or older on October 1, 1997, and lived in the city of 
Augsburg or one of two neighboring suburbs. Sampling of 
participants was done by age group (65-69, 70-74, > 75) to 
represent a broad range between age 65 and 83. The overall 
response rate of the eligible (n = 635) MONICA participants 
was 60.6%, yielding 385 MEMO participants. Informed con-
sent was obtained from all study participants before their 
examination.  
MRI Measurements 
  A cerebral MRI of the brain was performed in 267 study 
participants without contraindications. 118 participants did 
not receive an MRI because of metal body implants, artificial 
eye lenses or claustrophobia, or refusal of scanning. Partici-
pants with MRI were slightly younger (72.3 versus 73.7 
years, p = 0.003) and more often male (52.2 versus 47.8%,  
p = 0.77). All MRI scans were performed using a Phillips 
(Best, The Netherlands) 1.5 tesla machine at the Department 
of Radiology, Central Hospital of Augsburg. The MRI pro-
tocol included proton density (PD), T1, and T2 weighted 
images acquired with spin echo sequences with 20 axial 
slices, 5 or 6 mm thick, with an interslice gap of 1 or 1.2 
mm, respectively. All MRI scans were first examined visu-
ally by a single reader for periventricular and subcortical 
lesions, infarcts, and cortical as well as subcortical atrophy 
using an established rating scale [17]. Subcortical lesions 
were focal signal hyperintensities on proton density and T2-
weighted scans, which were not seen or exhibited only faint 
hypointensity on T1-weighted images. Periventricular le-
sions were abnormalities directly abutting the lateral ventri-
cle. They were graded on a severity scale (0-3) at the frontal 
and occipital horns and the body of the lateral ventricle, with 
the total periventricular lesion score being the sum of these 
three scores. Subcortical lesions were hyperintense foci sepa-
rated from the lateral ventricle. They were graded by size 
(small, medium, and large) and number. The total volume of 
subcortical lesions was assessed by multiplying each lesion 
by a size-dependent constant (0.0042 for small lesions, 0.114 
for medium lesions, and 0.95 for large lesions) and by sub-
sequent summation of the results. Infarcts were focal abnor-
malities with clearly defined borders, and they were isoin-
tense to cerebrospinal fluid on all sequences with a diameter 
>2 mm. Cortical atrophy was qualitatively assessed by a 
semi quantitative scale (0-3) applied to each lobe and to the 
sylvian fissure. The sum of the lobar scores represented the 
total cortical atrophy score (range 0-15). Subcortical atrophy 
was defined as the average of ventricular indexes relative to 
the width of the hemispheres measured at the level of frontal 
horns, occipital horns, and caudate nuclei [18].  
  The MRI scans of 26 RLS cases and 26 of the 241 non-
cases matched for age and sex, were examined visually a 
second time in a blinded fashion by one of us (MM) at Tho-
mas Jefferson University in Philadelphia, PA, USA. This 
was implemented to determine the consistency of infarct 
quantification via the use of a different rating scale.(18)
 For 
the second rating MRI T2 and proton density images were 
used to quantify the degree of subcortical lesions (leu-
koaraiosis) using the scale developed by the European Task 
Force on Age Related Subcortical Changes, and described 
elsewhere [19]. Briefly, subcortical ischemic changes were 
considered ill-defined hyperintensities >=5mm in diameter, 
and lacunar infarctions were considered well-defined areas 
of >2mm diameter with characteristics similar to CSF. Five 
different areas were assessed bilaterally for the presence of 
such lesions - the frontal areas, the parieto-occipital areas, 
the temporal areas, the diencephalic region (including the 
striatum, pallidum, thalamus, internal/external capsules, and 
insula), and the infratentorial region (including pons, cere-
bellum, mesencephalon, and medulla). Within the dien-
cephalic region, lesions were scored as 0 if none were pre-
sent that met measurement criteria, as 1 if a single focal le-
sion was present, as 2 if more than one lesion was present, 
and as 3 if lesions were confluent. Within the remaining 
anatomic locations, leukoaraiosis was scored as 0 if no le-
sions were present that met measurement criteria, as 1 if only 
focal lesions were present, as 2 if the lesions were confluent, 
and as 3 for diffuse involvement. A maximum total of 30 
points per scan/patient were possible based on this rating 
scale. The correlation between these two classifications 
based on different scales was high (spearman rank correla-
tion coefficient rho=0.78, p<0.001). 
Other Methodology 
  General medical history, history of neurological and psy-
chiatric diseases, family history, and current medication was 
assessed in a face to face interview in all participants. A 
stroke classification based on clinical symptoms was defined 
as one or more positive answers to a stroke symptom ques-
tionnaire and subsequent validation by medical records [20]. 
Silent infarction was defined as the presence of a hypodense 
(T1) or hyperdense (T2, proton density) lesion of >2 mm on 
the MRI scan and the answer ‘No’ to the question ‘Did you 
ever have a stroke that was diagnosed by a physician?’ made 
by the respective participant. In addition, all participants 
received a standardized neurological examination by one of 
two physicians. RLS was diagnosed according to questions 
assessing the International RLS Study Group diagnostic cri-
teria [8, 21].
 The RLS diagnosis was validated by either of 
the two physicians who were blinded to the results of the 
questions. In the group of MEMO participants with MRI this 
yielded twenty six RLS cases and 241 non cases. Blood was 
collected in all participants in a standardized way directly 
after the interview. The intima media thickness of the carotid 
artery was determined by B-mode ultrasonography using a 
standard protocol, but restricted to 120 participants due to 
logistic reasons.  
Statistical Analysis 
  Differences in categorical variables were compared be-
tween RLS cases and non-cases using the chi-squared test or 
the Fisher’s exact test (if more than 20% of the expected Prevalence of stroke in Restless Legs Syndrome  The Open Neurology Journal, 2010, Volume 4    75 
counts were 5 or less). Differences in continuous variables 
were tested with Student’s t-test. Serum levels for CRP and 
the subcortical lesion volume variable were log-transformed 
to approximate normal distribution. A logistic regression 
model was applied to determine the Odds Ratio (OR) of RLS 
case status for the dichotomized (yes-no) variables silent 
infarction, all stroke, and presence of large subcortical le-
sions. These outcomes were the dependent variable in the 
respective model and RLS case , age, gender and co morbid-
ities were included as the independent variables. For the sub-
cortical lesion volume and the cerebral atrophy analysis a 
linear regression model was used with the log-transformed 
volume and the atrophy score being the respective dependent 
variable and the variables listed above being the independent 
variables. All analyses were done using the Stata statistical 
package (version 9.0).  
  For the comorbidity adjustment two grouping variables 
were generated, one included vascular comorbidities (histo-
ries of either myocardial infarction or diabetes or heart fail-
ure or operation of the heart or large arteries), the other joint 
and bone related conditions (histories of either arthritis or 
operation of the large joints). These two grouping variables 
were coded 1 if one or more of the listed comorbidities were 
reported. Grouping of comorbidities was done to restrict the 
number of adjustment variables given the limited number of 
RLS cases.  
RESULTS 
  The prevalence of RLS among the 267 study participants 
with a cerebral MRI was 9.7%. This is comparable to the 
prevalence of RLS found in population based studies [2-7]. 
The overall prevalence of silent infarction in this sample was 
12.7% and that of all strokes, regardless if detected by MRI 
or clinical history or both, was 19.5%. 
  There was no significant difference in the prevalence of 
vascular risk factors or medical conditions between the 26 
RLS patients and all 241 non-cases (Table 1). There was a 
clearly higher all-stroke prevalence among the RLS cases 
than among non-cases, but this difference was not statisti-
cally significant (Table 2). When age, sex and co- morbid-
ities were taken into account in a logistic regression model, 
RLS case status was associated with a higher non-significant 
risk for stroke (Odds Ratio 2.46 with 95% CI 0.97-6.28, 
p=0.06). The prevalence of silent infarctions and large sub-
cortical lesions was also higher among the 26 RLS cases 
compared to the 241 controls but this result was also not 
statistically significant (Table 2). Similarly, the RLS cases 
had slightly more affected subcortical (volume) and more 
cerebral atrophy than the controls in univariate analysis. 
These differences were also not statistically significant. Ad-
ditional adjustment for age, sex and comorbidities in a linear 
regression model with cerebral atrophy score as the depend-
ent variable did not change the conclusions of these results 
either. Sensitivities, specificities, positive and negative pre-
Table 1.  Clinical Characteristics of the MEMO Study Participants According to RLS Status 
 
 RLS  Cases 
N = 26 
Controls 
N = 241 
P 
Age, mean   71.8 (4.2)  72.3 (4.4)  0.62 
Systolic. Blood pressure, mean   142.5 (17.1)  143.6 (16.9)  0.77 
Diastolic. Blood pressure, mean   81.7 (7.3)  82.2 (9.4)  0.78 
Hypertension measured 
1,  %  61.5 60.2 0.89 
History 
2 of hypertension, %   42.3  47.7  0.87 
History 
2 of diabetes, %  0.0  9.1  0.25 
Blood glucose, mean mg/dl   96.5 (2.2)  106.9 (2.4)  0.14 
History 
2 of myocardial infarction, %  3.9  7.5  0.79 
History 
2 of heart failure, %  7.7  10.0  0.18 
History 
2 of cancer, %  0.0  3.3  0.35 
BMI, mean   27.4 (3.2)  27.9 (3.7)  0.49 
Total cholesterol, mean mg/dl  258.2 (42.8)  264.7 (44.3)  0.47 
HDL-Cholesterol, mean mg/dl  50.3 (9.7)  49.7 (13.2)  0.82 
Ln Lpa
3, mean (SD) mg/dl  3.22 (1.06)  3.21 (1.15)  0.65 
Ln CrP
 4, mean (SD) mg/dl  0.53 (1.10)  0.70 (1.07)  0.45 
Creatinine, mg/dl  1.13 (0.49)  1.08 (0.30)  0.48 
Intima media right, mean mm  
 Thickness
5 left, mean mm  
0.887 (0.127) 
0.909 (0.108) 
0.916 (0.118) 
0.918 (0.124) 
0.41 
0.78 
Numbers in parentheses indicate standard deviations. 
1Systolic blood pressure >=140 mmHg and/ or diastolic blood pressure >= 90 mmHg. 
2Self reported history of a doctor diagnosis. 
3Means (SD) of log-transformed Lpa values, representing geometric means of (cases) and (non-cases). 
4Means (SD) of log-transformed CrP values, representing geometric means of (cases) and (non-cases). 
5Restricted to 14 cases and 106 controls. 76     The Open Neurology Journal, 2010, Volume 4  Walters et al. 
dictive values for the relationship of stroke to RLS are 
shown in Table 3.  
DISCUSSION 
  The major finding of this study is that all determined 
cerebrovascular changes were more frequently observed 
among RLS cases compared to non-cases. However, these 
differences did not reach statistical significance. The small 
number of RLS patients is one likely explanation of the lack 
of statistical significance between RLS and silent infarcts. 
Indeed a power analysis revealed that this study had a power 
of 27% and 15% to detect a significant difference between 
cases and non-cases for all strokes and silent infarcts, respec-
tively, given the observed prevalences of both. This would 
imply that a very large sample size would be needed for fu-
ture studies if the same methods would be applied. However, 
application of newer MRI techniques such as Flair images 
that were not available in the MEMO Study, is likely to im-
prove detection of ischemia and may help elucidate true dif-
ferences between RLS cases and non-cases. In addition, ap-
plication of sophisticated computer programs for MRI image 
analysis and infarct detection and measurement, as opposed 
to the visual rating of strokes by eye in the MEMO Study, 
might be helpful in this regard . Both the use of Flair images 
and computerized digital imaging analysis can contribute to 
enhance precision, sensitivity and, subsequently, might help 
to reduce sample sizes. Finally, recruiting patients and con-
trols without other vascular risk factors may be important in 
detecting differences on MRI that could be attributed to RLS 
alone. This would also be expected to reduce sampler size. 
Indeed we did a power calculation based on a much smaller 
but similar study we performed, where Flair images were 
utilized, automated quantification of infarct burden was em-
ployed and, for the purposes of the power calculation, pa-
tients with hypertension were eliminated (15). The power 
analysis was based upon volume load of microvascular dis-
ease and not the presence or absence of lesions. A t value of 
1.74 was obtained, corresponding to a standardized effect 
size (Cohen’s d) of approximately .78. Assuming this value 
is clinically meaningful in the power analysis, it was esti-
mated that power could be expected to reach an acceptable 
level of .80 if about 27 RLS patients and 27 controls were 
recruited [15].  
  Of course, an alternative explanation for our results is 
that they represent true negative findings. It is also conceiv-
able that the patients more severely affected by cardiovascu-
lar and cerebrovascular disease did not volunteer or were 
unable to participate in this study.  
Table 2.  MRI Findings According to RLS Case Status 
 
 RLS  cases 
N = 26 
controls 
N = 241 
p
6   p
7 
Dichotomous outcomes        Odds Ratio [95% CI]   
All stroke
 1  30.8% (8)  18.3% (44)    0.13  2.46 [0.97 – 6.28] 
4 0.06 
Silent infarction 
2  19.2% (5)  12.0% (29)    0.30  2.11 [0.71 – 6.27] 
4 0.18 
LargeSCL (>= 10mm) 
3  42.3% (11)  36.9% (89)   0.60  1.35 [0.56 – 3.22] 
4 0.50 
Continous outcomes  RLS cases 
N = 26 
controls 
N = 241 
p
6 Regression   
coefficient  [95% CI] 
p
7 
Subcortical lesion volume, log-
transformed mean, ml 
-0.92  -1.06  0.75  0.20 [-0.69 – 1.08] 
5 0.66 
Cerebral atrophy score, mean  8.96  8.58  0.48   0.56 [-0.44 – 1.56] 
5 0.27 
For Dichotomous outcomes numbers in parentheses equal number of patients.  
1Detected by MRI and/or by clinical history validated through medical record review. 
2Defined as an answer “no” to the question about physician diagnosed stroke but with an ischemic lesion on MRI. 
3SCL denotes large subcortical lesion. 
4Odds ratio and its 95% confidence interval, derived from logistic regression analysis with RLS status, age, gender and co morbidities as independent variables. 
5Regression coefficient and its 95% confidence interval, derived from linear regression analysis with RLS status, age, gender and co morbidities as independent variables. 
6Unvariate p-value. 
7P-value corresponding to the confidence interval. 
Table 3.  Sensitivity, Specificity, Positive and Negative Predictive Values and their 95% Confidence Intervals for RLS as a Marker 
for Stroke 
 
   RLS Cases  Controls             
   Total#RLS  Stroke #No  Stroke  Total#CTL Stroke  #No Stroke  Sensitivity (CI)  Specificity(CI)  Pos Pred Value (CI)  Neg Pred Value (CI) 
All Stroke  26  8  18  241  44  197  0.15 (0.06,0.25)  0.92 (0.88,0.95)  0.31 (0.13,0.49)  0.82 (0.77,0.87) 
Silent Stroke  26  5  21  241  29  212  0.15 (0.03,0.27)  0.91 (0.87, 0.95)  0.19 (0.04,0.34)  0.88 (0.84,0.92) 
Large SCL  26  11  15  241  89  152  0.11 (0.05,0.17)  0.91 (0.87, 0.95)  0.42 (0.23,0.61)  0.63 (0.57,0.69) 
sensitivity = number of pts with RLS and stroke / total number of pts with stroke. 
specificity = number of pts without RLS and without stroke / total number of pts without stroke. 
pos predictive value = # of pts with RLS and stroke / # of pts with RLS. 
negative predictive value = # of pts without stroke and without RLS / # of pts without RLS. 
CI = 95% confidence interval for the proportion. 
SCL = Subcortical Lesion. Prevalence of stroke in Restless Legs Syndrome  The Open Neurology Journal, 2010, Volume 4    77 
  A strength of this study is its population base, the possi-
bility to perform MRI with a standardized protocol and that 
MRI scans were obtained at the time of evaluation for RLS. 
A limitation is that patients could only be evaluated for RLS 
on one occasion and that the severity of RLS was not as-
sessed in order to associate the level of RLS severity with 
the number of silent infarcts on MRI scan. Another limita-
tion is that this is a cross-sectional study and we do not have 
good information on what came first: the silent infarct or the 
RLS.  
  Theoretical mechanisms as to how RLS/PLMS could 
lead to stroke or stroke could lead to RLS/PLMS are dis-
cussed elsewhere in detail and are beyond the scope of the 
current publication [1]. 
FUTURE DIRECTIONS 
  Determining whether there is a connection between 
stroke and RLS is of no small importance from a clinical 
point of view. The potential mechanisms interlinking stroke 
and RLS are multiple and have been explored in detail else-
where [1]. A key issue is whether or not the link between 
RLS and stroke is mediated by hypertension or not [1-8] and 
future studies should explore whether RLS is an independent 
risk factor for stroke or whether the risk for stroke in RLS is 
mediated through hypertension and other risk factors. 
 
CONCLUSIONS
 
  Based on recent publications reporting that patients with 
RLS and PLMS are at increased risk of hypertension, heart 
disease, and stroke,
1 we analyzed the association between 
RLS and MRI determined vascular brain changes in the 
MEMO-Study. Using the study’s cross-sectional design we 
only found statistically non-significant evidence for this as-
sociation despite considerable raw absolute differences. Fu-
ture studies should use prospective recruitment of patients 
and controls without other risk factors for stroke and the ap-
plication of newer MRI sequences and automated image 
analyses for stroke detection.  
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